Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. AWK
9. ACN
10. USO

Go back to Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data
(NASDAQ: SNDX) Delayed: 19.61 +0.29 (1.50%)
Previous Close $19.32    52 Week High $18.03 
Open $19.32    52 Week Low $8.97 
Day High $20.00    P/E N/A 
Day Low $19.21    EPS $0.00 
Volume 1,015,638